Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-1996 | 02-1996 | 11-1995 | 08-1995 | 05-1995 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,459 | 3,960 | 3,186 | 3,483 | 3,541 |
| TOTAL | $4,459 | $3,960 | $3,186 | $3,483 | $3,541 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,593 | N/A | N/A | N/A |
| Investments And Advances | 23,554 | 15,423 | 19,590 | 21,513 | 20,672 |
| Other Non-Current Assets | 7,038 | 6,413 | 2,784 | 5,378 | 5,595 |
| TOTAL | $30,592 | $27,429 | $22,374 | $26,891 | $26,267 |
| Total Assets | $35,051 | $31,389 | $25,560 | $30,374 | $29,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,067 | 4,309 | 2,222 | 2,115 | 2,052 |
| Accrued Expenses | 8,177 | 8,515 | 5,615 | 4,949 | 4,297 |
| Other current liabilities | 11,282 | 9,389 | 7,466 | 6,090 | 5,771 |
| TOTAL | $22,526 | $26,404 | $18,155 | $16,156 | $13,751 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 492 | 584 | 451 | 182 | 185 |
| TOTAL | $492 | $584 | $451 | $182 | $185 |
| Total Liabilities | $23,018 | $26,988 | $18,606 | $16,338 | $13,936 |
| Shareholders' Equity | |||||
| Common Shares | 58,165 | 40,283 | 37,780 | 37,320 | 36,171 |
| Other shareholders' equity | -25 | 333 | 341 | 215 | 169 |
| TOTAL | $58,140 | $40,616 | $38,121 | $37,535 | $36,340 |
| Total Liabilities And Equity | $81,158 | $67,604 | $56,727 | $53,873 | $50,276 |